0001209191-22-041791.txt : 20220711
0001209191-22-041791.hdr.sgml : 20220711
20220711164035
ACCESSION NUMBER: 0001209191-22-041791
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220711
FILED AS OF DATE: 20220711
DATE AS OF CHANGE: 20220711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ryder Steven
CENTRAL INDEX KEY: 0001872868
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 221077326
MAIL ADDRESS:
STREET 1: 234 CHURCH STREET, SUITE 1020
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
BUSINESS PHONE: 972-865-2219
MAIL ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2022-07-11
1
0001358762
REATA PHARMACEUTICALS INC
RETA
0001872868
Ryder Steven
5320 LEGACY DRIVE
PLANO
TX
75024
1
0
0
0
No securities are beneficially owned.
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Tracy Herson, attorney-in-fact
2022-07-11
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
FOR EXECUTING FORMS 3, FORMS 4, FORMS 5,
FORM 144 AND SCHEDULE 13D AND 13G
The undersigned hereby constitutes and appoints Michael D. Wortley, Manmeet S.
Soni, Tracy Herson, and Anne T. Yager, or any of them acting without the other,
with full power of substitution, as the undersigned's true and lawful
attorney-in-fact to:
1. Execute for and on behalf of the undersigned (a) any Form 3, Form 4 and Form
5 (including amendments thereto) in accordance with Section l 6(a) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), (b) Form 144
and ( c) Schedule 13D and Schedule 13G (including amendments thereto) in
accordance with Sections 13(d) and 13(g) of the Exchange Act, but only to the
extent each form or schedule relates to the undersigned's beneficial ownership
of securities of Reata Pharmaceuticals, Inc.;
2. Do and perform any and all acts for and on behalf of the undersigned that may
be necessary or desirable to complete and execute any Form 3, Form 4, Form 5,
Form 144, Schedule 13D or Schedule 13G (including amendments thereto) and timely
file the forms or schedules with the Securities and Exchange Commission and any
stock exchange or quotation system, self-regulatory association or any other
authority, and provide a copy as required by law or advisable to such persons as
the attorney-in-fact deems appropriate; and
3. Take any other action in connection with the foregoing that, in the opinion
of the attorney-in-fact, may be of benefit to, in the best interest of or
legally required of the undersigned, it being understood that the documents
executed by the attorney-in-fact on behalf of the undersigned pursuant to this
Power of Attorney shall be in the form and shall contain the terms and
conditions as the attorney-in-fact may
approve in the attorney-in-fact's discretion.
The undersigned hereby grants to the attorney-in-fact full power and authority
to do and perform all and every act requisite, necessary or proper to be done in
the exercise of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and confirming
all that the attorney-in-fact shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers granted herein. The undersigned
acknowledges that the attorneys-in-fact, in serving in such capacity at the
request of the undersigned, are not assuming (nor is Reata Pharmaceuticals, Inc.
assuming) any of the undersigned's responsibilities to comply with Section 16 of
the Exchange Act.
The undersigned agrees that the attorney-in-fact may rely entirely on
information furnished orally or in writing by or at the direction of the
undersigned to the attorney-in-fact. The undersigned also agrees to indemnify
and hold harmless Reata Pharmaceuticals, Inc. and the attorney-in-fact against
any losses, claims, damages or liabilities ( or actions in these respects) that
arise out of or are based US 3840731 v.2 upon any untrue statements or omissions
of necessary facts in the information provided by or at the direction of the
undersigned, or upon the lack of timeliness in the delivery of information by or
at the direction of the undersigned, to the attorney-in fact for purposes of
executing,
acknowledging, delivering or filing a Form 3, Form 4, Form 5, Form 144, Schedule
13D or Schedule 13G (including any amendments, corrections, supplements or other
changes thereto) with respect to the undersigned's holdings of and transactions
in securities issued by Reata
Pharmaceuticals, Inc., and agrees to reimburse Reata Pharmaceuticals, Inc. and
the attorney-in-fact on demand for any legal or other expenses reasonably
incurred in connection with investigating or defending against any such loss,
claim, damage, liability or action.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Form 3, Form 4, Form 5, Form 144,
Schedule 13D and Schedule 13G (including any amendments, corrections,
supplements or other changes thereto) with respect to the
undersigned's holdings of and transactions in securities issued by Reata
Pharmaceuticals, Inc., unless earlier revoked by the undersigned in a signed
writing delivered to the attorney-in-fact. This Power of Attorney does not
revoke any other power of attorney that the undersigned has previously granted.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date written below.
Signature: /s Steven W. Ryder, M.D.
Date: June 17, 2022